A detailed history of Capstone Financial Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Capstone Financial Advisors, Inc. holds 9,924 shares of PFE stock, worth $272,513. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,924
Previous 9,986 0.62%
Holding current value
$272,513
Previous $277,000 -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $1,566 - $1,835
-62 Reduced 0.62%
9,924 $277,000
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $85,566 - $98,257
-3,305 Reduced 24.87%
9,986 $277,000
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $1,123 - $1,459
43 Added 0.32%
13,291 $382,000
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $64,051 - $74,869
1,996 Added 17.74%
13,248 $439,000
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $29,835 - $34,518
826 Added 7.92%
11,252 $412,000
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $46,401 - $60,407
-1,178 Reduced 10.15%
10,426 $425,000
Q4 2022

Feb 15, 2023

SELL
$41.75 - $54.5 $20,207 - $26,378
-484 Reduced 4.0%
11,604 $594,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $21,442 - $26,175
490 Added 4.22%
12,088 $529,000
Q2 2022

Sep 02, 2022

SELL
$46.53 - $55.17 $3,768 - $4,468
-81 Reduced 0.69%
11,598 $608,000
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $7,548 - $9,353
165 Added 1.43%
11,679 $605,000
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $8,470 - $12,556
205 Added 1.81%
11,514 $680,000
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $12,599 - $16,184
321 Added 2.92%
11,309 $486,000
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $47,544 - $53,860
1,324 Added 13.7%
10,988 $430,000
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $151,743 - $171,135
-4,531 Reduced 31.92%
9,664 $350,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $38,758 - $49,284
1,158 Added 8.88%
14,195 $523,000
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $153,352 - $179,917
4,830 Added 58.85%
13,037 $478,000
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $27,381 - $39,122
-1,013 Reduced 10.99%
8,207 $268,000
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $59,519 - $67,546
1,808 Added 24.39%
9,220 $361,000
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $3,086 - $4,002
-95 Reduced 1.27%
7,412 $266,000
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $1,442 - $1,619
-39 Reduced 0.52%
7,507 $325,000
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $16,125 - $17,716
430 Added 6.04%
7,546 $320,000
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $38 - $43
1 Added 0.01%
7,116 $311,000
Q3 2018

Nov 20, 2018

BUY
$34.47 - $41.81 $34 - $41
1 Added 0.01%
7,115 $314,000
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $1,595 - $1,851
-50 Reduced 0.7%
7,114 $252,000
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $238,274 - $252,817
7,164
7,164 $259,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Capstone Financial Advisors, Inc. Portfolio

Follow Capstone Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capstone Financial Advisors, Inc. with notifications on news.